Bulletin
Investor Alert

New York Markets Open in:

BioNTech SE ADR

NAS: BNTX

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Dec 7, 2022, 4:19 a.m.

/zigman2/quotes/214419716/composite

$

160.50

Change

-1.12 -0.69%

Volume

Volume 20

Real time quotes

/zigman2/quotes/214419716/composite

Previous close

$ 161.62

$ 161.62

Change

-5.09 -3.05%

Day low

Day high

$158.36

$166.00

Open

52 week low

52 week high

$117.08

$312.96

Open

Annual Financials for BioNTech SE ADR

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 69.48M150.51M121.54M549.84M22.43B
Cost of Goods Sold (COGS) incl. D&A 22.34M40.47M55.73M67.27M113.59M
COGS excluding D&A 10.51M14.54M17.79M23.11M24.7M
Depreciation & Amortization Expense 11.83M25.94M37.94M44.17M88.88M
Depreciation -14.13M19.47M25.21M69.03M
Amortization of Intangibles -11.81M18.47M18.95M19.86M
Gross Income 47.14M110.03M65.81M482.56M22.32B
20172018201920202021 5-year trend
SG&A Expense 118.58M179.08M271.24M786.46M1.47B
Research & Development 85.31M147.15M222.66M676.96M1.08B
Other SG&A 33.27M31.94M48.59M109.5M-
Other Operating Expense ---19,380-
Unusual Expense 376,73056,628364,87596.16M3.72B
EBIT after Unusual Expense (71.82M)(69.11M)(205.8M)(400.08M)17.12B
Non Operating Income/Expense (26.63M)12.65M4.89M234.35M667.23M
Non-Operating Interest Income 2.41M2.35M1.99M1.78M1.77M
Equity in Affiliates (Pretax) -----
Interest Expense 762,4842.03M1.92M2.28M6.38M
Gross Interest Expense 762,4842.03M1.92M2.28M6.38M
Interest Capitalized -----
Pretax Income (96.81M)(56.13M)(200.84M)(166.23M)17.78B
Income Tax 50,757707,850(299,959)(183.56M)5.62B
Income Tax - Current Domestic (29.29M)(15.38M)-19,3805.36B
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic 29.34M16.08M-(183.57M)258.74M
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates (87,979)(99,099)---
Other After Tax Income (Expense) -----
Consolidated Net Income (96.95M)(56.94M)(200.54M)17.33M12.17B
Minority Interest Expense (334,997)(286,679)(129,833)--
Net Income (96.61M)(56.65M)(200.41M)17.33M12.17B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (96.61M)(56.65M)(200.41M)17.33M12.17B
Preferred Dividends -----
Net Income Available to Common (96.61M)(56.65M)(200.41M)17.33M12.17B
EPS (Basic) -(5.34)(0.95)0.0749.86
Basic Shares Outstanding 9.27M10.6M211.5M235.44M244M
EPS (Diluted) (10.43)(5.34)(0.95)0.0746.84
Diluted Shares Outstanding 9.27M10.6M211.5M248.53M259.7M
EBITDA (59.61M)(43.12M)(167.49M)(259.75M)20.93B
Link to MarketWatch's Slice.